Skip to main content
SpringerLink
Log in

The place of diuretics in the treatment of hypertension: A historical review of classical experience over 30 years

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Thiazide diuretics have been the mainstay of antihypertensive therapy for over 30 years. Their precise mechanism of antihypertensive action is still incompletely understood. They reduce arterial pressure initially through a fall in plasma volume and cardiac output. However, with chronic administration cardiac output tends to return towards pretreatment levels, suggesting that the long-term pressure reduction is mediated through a reduction in vascular resistance. Although multiple lines of evidence suggest that salt and water loss is an essential part of the mechanism, at least in some cases an indirect vasodilator effect may play a role as well. The antihypertensive efficacy of diuretics is proven; they are at least as effective as other classes of antihypertensive drugs. They have been shown to protect against stroke, but not against mortality from myocardial infarction. There is some concern about the metabolic side effects, such as hypokalemia, hyperglycemia, and hyperlipidemia. In order to minimize these side effects the lowest effective dose should be used. Diuretics are likely to remain first-line antihypertensive agents, but they should be considered as one of several possible choices for the initial therapy among other classes, such as beta-blockers, ACE inhibitors, or calcium entry blockers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Megibow RS, Pollak H, Stollerman GH, et al. The treatment of hypertension by accelerated sodium depletion.J Mt Sinai Hosp NY 1948;15:233–239.

    Google Scholar 

  2. Novello FC, Sprague J. Benzothiazine dioxides as novel diuretics.J Am Chem Soc 1957;71:2028–2029.

    Google Scholar 

  3. Hollander W, Wilkins RW. Chlorothiazide: A new type of drug for the treatment of arterial hypertension.Boston Med Q 1957;8:69–75.

    Google Scholar 

  4. Wilkins RW. New drugs for hypertension with special reference to chlorothiazide.N Engl J Med 1957;257:1026–1030.

    PubMed  Google Scholar 

  5. Freis ED, Wanko A, Silson IM, et al. Treatment of essential hypertension with chlorothiazide (Diuril).JAMA 1958;166:137–140.

    Google Scholar 

  6. Moser M. Diuretics in the management of hypertension.Med Clin North Am 1987;71:935–946.

    PubMed  Google Scholar 

  7. Frohlich ED. Diuretics in hypertension.J Hypertens 1987;5(Suppl 3):S43-S49.

    Google Scholar 

  8. Rose BD, Tinka LA. Diuretics. In: Kaplan NM, Brenner BM, Laragh JH, eds.The kidney in hypertension. New York: Raven Press, 1987:179–196.

    Google Scholar 

  9. Pecker MS. Pathophysiologic effects and strategies for long-term diuretic treatment of hypertension. In: Laragh JH, Brenner BM, eds.Hypertension: Pathophysiology, diagnosis and management. New York: Raven Press, 1990:2143–2167.

    Google Scholar 

  10. Kaplan NM. Principles of antihypertensive drug therapy: An overview. In: Kaplan NM, Brenner BM, Laragh JM, eds.The kidney in hypertension. New York: Raven Press, 1987:127–144.

    Google Scholar 

  11. Tobian L. Why do diuretics lower blood pressure in essential hypertension?Ann Rev Pharmacol 1967;7:399–408.

    PubMed  Google Scholar 

  12. Birkenhäger WH. Diuretics and blood pressure reduction: Physiologic aspects.J Hypertens 1990;8(Suppl 2):S3-S7.

    Google Scholar 

  13. Frohlich ED, Schnaper HW, Wilson IM, et al. Hemodynamic alterations in hypertensive patients due to chlorothiazide.N Engl J Med 1960;252:1261–1263.

    Google Scholar 

  14. Lohmöller G, Lohmöller R, Pfeffer MA, et al. Mechanisms of immediate hemodynamic effects of chlorothiazide.Am Heart J 1975;89:487–492.

    PubMed  Google Scholar 

  15. Conway J, Lauwers P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide.Circulation 1967;22:21–22.

    Google Scholar 

  16. Tarazi RC, Dustan HP, Frohlich ED. Long-term thiazide therapy in essential hypertension: Evidence for persistent alterations in plasma volume and renin activity.Circulation 1970;41:709–717.

    PubMed  Google Scholar 

  17. Wilson IM, Freis ED. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide.Circulation 1962;26:405–408.

    PubMed  Google Scholar 

  18. Winer BM. The antihypertensive mechanism of salt depletion induced by hydrochlorothiazide.Circulation 1961;24:788–796.

    PubMed  Google Scholar 

  19. Wilson WR, Okun R. The acute hemodynamic effects of diazoxide in man.Circulation 1963;28:89–93.

    PubMed  Google Scholar 

  20. Mironneau J, Savineau JP, Mironneau C. Compared effects of indapamide, hydrochlorothiazide and chlortalidone on electrical and mechanical activities in vascular smooth muscle.Eur J Pharmacol 1981;75:109–113.

    PubMed  Google Scholar 

  21. Freis ED. How diuretics lower blood pressure.Am Heart J 1983;106:185–187.

    PubMed  Google Scholar 

  22. Dupont AG, Schoors DF, Six RO, et al. Antihypertensive efficacy of low dose torasemide in essential hypertension: A placebo-controlled study.J Human Hypertens 1988;2:265–268.

    Google Scholar 

  23. Friedel HA, Buckley MMT. Torasemide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension, congestive heart failure and oedema associated with renal and hepatic disease.Drugs 1991;41:81–103.

    PubMed  Google Scholar 

  24. Dupont AG, Gerlo E, Van der Niepen P, et al. Renal hemodynamic effects of torasemide and furosemide in normal man.Arzneim Forsch/Drug Res 1988;38(II):172–175.

    Google Scholar 

  25. Webster JA, Dollery CT. Antihypertensive action of bendroflumethiazide: Increased prostacyclin production.Clin Pharmacol Ther 1980;28:751–758.

    PubMed  Google Scholar 

  26. Vaughan ED Jr, Carey RM, Peach MJ, et al. The renin response to diuretic therapy: A limitation of antihypertensive potential.Circ Res 1978;421:376–381.

    Google Scholar 

  27. Van Brummelen P, Man in 't Veld AJ, Schalekamp MAHD. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and non-responders.Clin Pharmacol Ther 1980;27:328–336.

    PubMed  Google Scholar 

  28. Weber MA, Drayer JI, Rev A, et al. Disparate patterns of aldosterone response during diuretic treatment of hypertension.Ann Intern Med 1977;87:558–563.

    PubMed  Google Scholar 

  29. Leonetti G, Terzoli L, Sala C, et al. Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.Clin Sci Mol Med 1978;55:307s-309s.

    Google Scholar 

  30. Gavras H, Brunner HR, Laragh JH, et al. A converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertension.N Engl J Med 1974;291:817–821.

    PubMed  Google Scholar 

  31. Vaughan ED, Laragh JH, Gavras I, et al. Volume factors in low and normal renin essential hypertension.Am J Cardiol 1973;32:523–532.

    PubMed  Google Scholar 

  32. Laragh JH. Modification of stepped care approach to antihypertensive therapy.Am J Med 1984;77:78–86.

    Google Scholar 

  33. Freis ED, Wanho A, Schnaper HE, et al. Mechanism of the altered blood pressure responsiveness induced by chlorothiazide.J Clin Invest 1960;39:1277–1281.

    PubMed  Google Scholar 

  34. Weidmann P, Beretta-Piccoli C, Meier A, et al. Antihypertensive mechanism of diuretic treatment with chlortalidone. Complementary roles of sympathetic axis and sodium.Kidney Int 1983;23:320–325.

    PubMed  Google Scholar 

  35. Lake CR, Ziegler MG, Coleman MD, et al. Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients.Clin Pharmacol Ther 1979;26:428–432.

    PubMed  Google Scholar 

  36. Coleman TG, Granger HJ, Guyton AC. Whole-body circulatory autoregulation and hypertension.Circ Res 1971;28(Suppl 2):76–87.

    PubMed  Google Scholar 

  37. De Wardener HE, MacGregor GA. The relations of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension.Medicine 1983;62:310–326.

    PubMed  Google Scholar 

  38. Gifford RW Jr. Long-term clinical trials in hypertension.J Hypertens 1990;8(Suppl 2):S17-S22.

    Google Scholar 

  39. Moser M. Antihypertensive medications: Relative effectiveness and adverse reactions.J Hypertens 1990;8(Suppl 2):S9-S16.

    Google Scholar 

  40. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: Principal results.Br Med J 1985;291:97–102.

    Google Scholar 

  41. Multiple Risk Factor Intervention Research Group. Baseline resting electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial.Am J Cardiol 1985;55:1–15.

    Google Scholar 

  42. Kannel WB, Cupplas LA, D'Agostino RB, et al. Hypertension, antihypertensive treatment, and sudden coronary death: the Framingham Study.Hypertension 1988;11(Suppl II):II45-II50.

    PubMed  Google Scholar 

  43. Freis ED. The cardiotoxicity of thiazide diuretics: Review of the evidence.J Hypertens 1990;8(Suppl 2):S23-S32.

    Google Scholar 

  44. Shannon RP, Wei JY, Rosa RM, et al. The effect of age and sodium depletion on cardiovascular response to orthostasis.Hypertension 1986;8:438–443.

    PubMed  Google Scholar 

  45. Fichmann MP, Vorherr H, Kleeman CR, et al. Diuretic-induced hyponatremia.Ann Intern Med 1971;75:853–863.

    PubMed  Google Scholar 

  46. Holland OB, Nixon JV, Kuhert L. Diuretic-induced ventricular ectopic activity.Am J Med 1981;70:762–768.

    PubMed  Google Scholar 

  47. Hollifield JW, Slaton PE. Thiazide diuretics, hypokalemia, and cardiac arrhythmia.Acta Med Scand 1981;Suppl 647:67–73.

    Google Scholar 

  48. Medical Research Council Working Party on Mild to Moderate Hypertension. Ventricular extra-systoles during thiazide treatment: Substudy of MRC mild hypertension trial.Br Med J 1983;287:1249–1253.

    Google Scholar 

  49. Madias JE, Madias NE, Gavras HP. Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension.Arch Intern Med 1984;144:2171–2176.

    PubMed  Google Scholar 

  50. Papademetriou V, Burris JF, Notargiacomo A, et al. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension.Arch Intern Med 1988;148:1272–1276.

    PubMed  Google Scholar 

  51. Struthers AD, Whitesmith R, Reid JL. Prior thiazide diuretic treatment increases adrenaline-induced hypokalemia.Lancet 1983;1:1358–1360.

    PubMed  Google Scholar 

  52. Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta receptor stimulation of circulating epinephrine.N Engl J Med 1983;309:1414–1419.

    PubMed  Google Scholar 

  53. Norderhang JE, Johanessen KA, Von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction.Circulation 1985;71:645–649.

    PubMed  Google Scholar 

  54. Araoye MA, Chang MY, Khatri IM, et al. Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension.JAMA 1978;240:1863–1866.

    PubMed  Google Scholar 

  55. Ram CVS, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension: Effects on potassium wastage and blood pressure control.Arch Intern Med 1981;145:1015–1019.

    Google Scholar 

  56. Morgan DB, Davidson C. Hypokalemia and diuretics: An analysis of publications.Br Med J 1980;230:905–908.

    Google Scholar 

  57. Case DB, Pickering TG, Laragh JH. High sodium intake prevents adverse metabolic effects of diuretic treatment without reversing antihypertensive effect.Clin Res 1984;32:329A.

    Google Scholar 

  58. Dyckner T, Wester PO. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusion in patients on diuretic therapy.Am Heart J 1979;97:12–18.

    PubMed  Google Scholar 

  59. Cohen L, Kitzes R. Magnesium sulfate and digitalis-toxic arrhythmias.JAMA 1983;249:2808–2810.

    PubMed  Google Scholar 

  60. Lim P, Jacobs E. Magnesium deficiency in patients on long-term diuretic therapy for heart failure.Br Med J 1972;2:620–622.

    Google Scholar 

  61. Ryan MP, Ryan MF, Connihan TB. The effect of diuretics on lymphocyte magnesium and potassium.Acta Med Scand 1981;647(Suppl):153–161.

    Google Scholar 

  62. Murphy MB, Lewis PJ, Kohner E, et al. Glucose intolerance in hypertensive patients treated with diuretics; A 14-year follow-up.Lancet 1982;2:1293–1295.

    PubMed  Google Scholar 

  63. Bengtsson C, Blohme G, Lapidus L, et al. Do antihypertensive drugs precipitate diabetes?Br Med J 1984;289:1425–1497.

    Google Scholar 

  64. Dupont AG. Insulin sensitivity and hypertension.Eur J Med 1991;2:143–147.

    Google Scholar 

  65. Damhurst A, Powell SH, Pensky J. Aggravation by propranolol of hyperglycaemic effects of hydrochlorothiazide in type II diabetics without alteration of insulin secretion.Lancet 1985;1:123–126.

    PubMed  Google Scholar 

  66. Helderman JH, Elahi D, Andersen DK, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium.Diabetes 1983;32:106–111.

    PubMed  Google Scholar 

  67. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.N Engl J Med 1989;321:868–873.

    PubMed  Google Scholar 

  68. Ames RP, Hill P. Elevation of serum lipid levels during diuretic therapy of hypertension.Am J Med 1976;61:748–757.

    PubMed  Google Scholar 

  69. Weidmann P, Gerber A, Mordasini R. Effects of antihypertensive therapy on serum lipoproteins.Hypertension 1983;5(Suppl III):III120-III131.

    PubMed  Google Scholar 

  70. Weidmann P, Uehlinger DE, Gerber A. Antihypertensive treatment and serum lipoproteins.J Hypertens 1985;3:297–306.

    PubMed  Google Scholar 

  71. MacMahon SW, Macdonald GJ. Antihypertensive treatment and plasma lipoprotein levels: The association in data from a population study.Am J Med 1986;80(Suppl 2A):40–47.

    Google Scholar 

  72. Boehringer K, Weidmann P, Madosini R, et al. Menopausedependent plasma lipoprotein alterations in diuretic treated women.Ann Intern Med 1982;97:206–209.

    PubMed  Google Scholar 

  73. Lardinois CK, Neumann SI. The effect of antihypertensive agents on serum lipids and lipoproteins.Arch Intern Med 1984;148:1280–1288.

    Google Scholar 

  74. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to dendrofluazide and propranolol for the treatment of mild hypertension.Lancet 1981;8:539–542.

    Google Scholar 

  75. Berglund G, Andersson O. Beta-blockers or diuretics in hypertension? A six-year follow-up of blood pressure and metabolic side effects.Lancet 1981;1:744–747.

    PubMed  Google Scholar 

  76. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease.Ann Intern Med 1979;90:85–91.

    PubMed  Google Scholar 

  77. Lipids Research Clinics Primary Prevention Trial Results. II. Relationship of reduction in incidence of coronary heart disease to cholesterol lowering.JAMA 1984;144:1947–1953.

    Google Scholar 

  78. Brunner HR, Ménard J, Waeber B, et al. Treating the individual hypertensive patients: Considerations on dose, sequential monotherapy and drug combination.J Hypertens 1990;8:3–11.

    PubMed  Google Scholar 

  79. Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension.Arch Intern Med 1990;150:1175–1183.

    PubMed  Google Scholar 

  80. 80.SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension.JAMA 1991;265:3255–3264.

    Google Scholar 

  81. Dahlöf N, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension).Lancet 1991;338:1281–1285.

    PubMed  Google Scholar 

  82. MRC Working Party, Medical Research Council trial of treatment of hypertension in older adults: principal results.Brit Med J 1992;304:505–512.

    Google Scholar 

  83. Robertson JIS. The case for antihypertensive drug treatment in subjects over the age of sixty.Cardiovasc Drugs Ther 1992;6:580–583.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Hypertension and Clinical Pharmacology Unit, Free University of Brussels (AZ-VUB), Brussels, Belgium

    Alain G. Dupont

Authors
  1. Alain G. Dupont
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dupont, A.G. The place of diuretics in the treatment of hypertension: A historical review of classical experience over 30 years. Cardiovasc Drug Ther 7 (Suppl 1), 55–62 (1993). https://doi.org/10.1007/BF00877958

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00877958

Key Words

Search

Navigation